Precocious Puberty - Long Essay

Definition

• Textbook of Family Medicine 9e, p. 1038; Tietz Textbook of Laboratory Medicine, p. 2369

Classification

1. Central (True / GnRH-Dependent) Precocious Puberty (CPP)

• Results from premature activation of the hypothalamic-pituitary-gonadal (HPG) axis
• GnRH-stimulated release of LH and FSH drives early maturation of gonads
• The sequence of sexual development mirrors normal puberty but occurs earlier
• In girls, the cause is idiopathic in ~90% of cases; in boys, idiopathic cases account for less than 10% - a CNS cause is found in approximately two thirds of boys

2. Peripheral (Pseudo / GnRH-Independent) Precocious Puberty

• Sex steroid secretion occurs independent of pituitary gonadotropin release
• LH and FSH are suppressed (paradoxically low despite high sex steroids)
• Caused by autonomous gonadal activity, adrenal disorders, exogenous sex steroids, or specific genetic mutations

Additional Subclassifications

• Goldman-Cecil Medicine; Textbook of Family Medicine 9e; Berek & Novak's Gynecology

Epidemiology

• Precocious puberty is 20 times more common in girls than in boys
• More than 75% of children investigated for precocious puberty receive benign diagnoses that are normal variations and require no treatment
• In girls, the vast majority (90%) are idiopathic/constitutional
• Children with developmental disabilities have a higher incidence of precocity
• Constitutional (idiopathic) sexual precocity represents the "early 2.5%" tail of the Gaussian age-distribution curve for pubertal onset, and is often familial
• Berek & Novak's Gynecology, p. 346; Textbook of Family Medicine 9e, p. 1039

Pathophysiology

Normal Puberty - Brief Review

Mechanism in CPP

Mechanism in Peripheral Precocious Puberty

• Autonomous ovarian/testicular activity
• Adrenal gland pathology
• Exogenous sex steroid exposure
• Constitutive activation of gonadotropin receptors

• Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine 22E; Ganong's Review of Medical Physiology

Etiology

Central (GnRH-Dependent) Causes

• Most common cause in girls (~90%)
• Often familial; represents early normal variation
• Slowly progressive in most; rapidly progressive in a few

• Hypothalamic hamartoma: Most common organic cause; a congenital malformation composed of heterotopic nerve tissue with GnRH-secreting neurons. Does not usually grow. Associated with gelastic (laughing) seizures, behavioral disturbances, and mental retardation. Appears as isodense, non-enhancing mass on imaging. Extreme precocity before age 3 with absent tumor markers is characteristic.
• CNS tumors (astrocytomas, craniopharyngiomas, gliomas, optic nerve gliomas in neurofibromatosis)
• hCG-secreting germinomas of the hypothalamus or pineal gland - stimulate gonadal testosterone production via hCG (acts on LH receptors)
• Hydrocephalus, craniostenosis, arachnoid cysts, septo-optic dysplasia
• CNS infections and inflammatory conditions
• Seizure disorders
• Prior CNS radiation or trauma
• Neurofibromatosis type 1 (documented to lead to GnRH-dependent CPP)
• Goldman-Cecil Medicine; Berek & Novak's Gynecology, p. 352; Tietz Laboratory Medicine

Peripheral (GnRH-Independent) Causes

• Most commonly due to 21-hydroxylase deficiency; also 11β-hydroxylase and 3β-hydroxysteroid dehydrogenase deficiencies
• Classic forms: virilization + growth acceleration + advanced bone age
• Non-classic (late-onset): premature adrenarche and acne in childhood/adolescence
• 5-10% of children presenting with premature adrenarche have late-onset adrenal hyperplasia
• Boys with poorly controlled CAH may secondarily develop gonadotropin-dependent CPP

• Autosomal dominant disorder
• Activating mutations of the LH receptor causing constitutive, ligand-independent testosterone secretion
• Signs of puberty appear around age 2 years in boys
• LH is low (gonadotropin-independent); testosterone is markedly elevated

• Caused by somatic (postzygotic) activating mutations in the GNAS1 gene (encoding the Gα subunit of G proteins)
• Impairs GTPase activity of Gα → constitutive activation of adenylyl cyclase → unrestrained sex steroid synthesis
• Classic triad: precocious puberty + polyostotic fibrous dysplasia + café-au-lait skin spots (with irregular "coast of Maine" borders)
• Most common in girls; also affects adrenals, pituitary, thyroid (autonomous multi-endocrine activation)
• Fibrous dysplasia results from Gα activation in skeletal stem cells → immature woven bone + fibrotic marrow stroma

• Androgen or estrogen-secreting tumors of the adrenal gland, ovaries, or testes
• Leydig cell tumors of the testis secrete testosterone autonomously
• Adrenal rests within the testis (in CAH with chronic ACTH stimulation) - regress with glucocorticoid therapy

• High TSH levels cross-react with FSH receptors (intrinsic FSH-like activity of elevated TSH)
• Unlike other causes, associated with skeletal and growth delays rather than acceleration

• Environmental endocrine disruptors, accidental ingestion of oral contraceptives, topical testosterone, phytoestrogens
• Tietz Textbook, p. 2369-2370; Harrison's 22E, pp. 3152-3153; Goldman-Cecil Medicine; Berek & Novak's Gynecology

Clinical Features

Girls

• Thelarche (breast budding) is usually the first sign
• Followed by pubic/axillary hair, growth acceleration, body odor, acne
• Menarche may follow - often premature vaginal bleeding
• Accelerated linear growth (may be initially tall for age but ultimately short due to premature epiphyseal fusion)
• Advanced bone age on X-ray
• Behavioral and psychological changes (distress, social maladjustment)

Boys

• Testicular enlargement (>4 mL or >2.5 cm) is the first sign in true CPP
• Followed by pubic/axillary hair, penile growth, deepening of voice, acne, body odor
• Growth spurt
• In pseudo-precocious puberty due to CAH or testotoxicosis: small testes (testes not driven by LH) despite marked virilization

Benign Variants (Incomplete Precocious Puberty)

• Berek & Novak's Gynecology, pp. 349-350; Textbook of Family Medicine 9e

Complications

1. Short final adult stature - the most important complication; premature epiphyseal closure limits growth potential
2. Psychological distress - early secondary sexual development in a school-age child causes social maladjustment, anxiety, low self-esteem
3. Early menarche - associated with increased risk of breast and endometrial cancer (lifetime estrogen exposure)
4. Premature adrenarche - long-term risk of PCOS, hyperinsulinemia, acanthosis nigricans, dyslipidemia

Diagnosis

Step 1: Clinical Assessment

1. Complete medical, birth, and family history including timing of pubertal events
2. Assess for neurological symptoms or signs
3. Examine and assign Tanner stage (breast + pubic hair for girls; genital + pubic hair for boys)
4. Look for associated findings: abdominal mass, café-au-lait spots, fibrous dysplasia, thyroid enlargement
5. Bone age (left wrist X-ray) - advanced bone age supports true precocious puberty

Step 2: Hormonal Evaluation

Step 3: Imaging

• MRI brain with contrast - for all boys and girls with CPP to exclude CNS lesion; mandatory in boys (2/3 have organic cause) and in girls with early onset or neurological features
• Ultrasound of abdomen and pelvis - ovarian/adrenal tumor, ovarian cysts, uterine volume (uterine volume most sensitive discriminator between premature thelarche and true CPP)
• CT adrenals - if DHEAS elevated to exclude adrenal tumor
• Testicular ultrasound - to exclude Leydig cell tumor

Diagnostic Algorithm Summary

• High LH + elevated sex steroids → GnRH-dependent CPP → MRI brain
• Low LH + high testosterone + high 17-OHP → CAH → ACTH stimulation test
• Low LH + high testosterone + high DHEAS → Adrenal tumor → CT adrenals
• Low LH + high testosterone, normal 17-OHP and DHEAS → Testicular tumor or LH receptor mutation → testicular US ± genetic testing
• Low LH + café-au-lait spots + fibrous dysplasia → McCune-Albright syndrome → GNAS1 mutation
• Precocious puberty + growth delay + hypothyroidism → Severe primary hypothyroidism
• Tietz Textbook, pp. 2369-2371; Harrison's 22E, pp. 3152-3153; Berek & Novak's Gynecology; Goldman-Cecil Medicine

Treatment

1. Central (GnRH-Dependent) Precocious Puberty

• Documented progression of pubertal development over 3-6 months
• Tanner stage ≥3 genital development (in boys)
• Rapid linear growth or advanced bone age threatening final height
• Psychological distress
• Most effective for improving final height if initiated before age 6

• Leuprolide acetate depot: 3-month depot 11.25 mg or 30 mg IM; or 6-month depot (triptorelin 22.5 mg every 6 months)
• Triptorelin (pamoate) depot formulations

• Suppresses gonadotropins and sex steroids
• Halts early pubertal development
• Delays accelerated bone maturation
• Prevents premature epiphyseal closure
• Promotes final adult height gain
• Mitigates psychosocial consequences
• Puberty resumes after discontinuation
• Does not cause osteoporosis or long-term weight gain at recommended doses
• No consensus on optimal age of withdrawal; approximately 11-11.5 years of chronological age has been recommended

2. Peripheral (GnRH-Independent) Precocious Puberty

• Goldman-Cecil Medicine; Harrison's 22E; Tietz Textbook; Berek & Novak's Gynecology

Premature Thelarche - Special Note

• Breast enlargement in girls < 2 years (rarely after age 4) without other pubertal signs
• No significant nipple or areolar development
• May be caused by increased estrogen sensitivity or follicular cysts secreting estradiol
• Benign, self-limited - reassurance and follow-up only
• Uterine volume measurement is the most sensitive and specific discriminator between premature thelarche and early true CPP
• In most cases, adult height, pubertal timing, and reproductive function remain normal

Premature Adrenarche - Special Note

• Early appearance of pubic/axillary hair due to early adrenal androgen production (DHEA/DHEAS)
• Rule out non-classic CAH with ACTH stimulation test
• Benign variant if no breast development or progression
• Long-term risk of PCOS, hyperinsulinemia, acanthosis nigricans, and dyslipidemia - especially if fetal growth was restricted (low birth weight)
• May represent the first sign of insulin resistance
• Treat co-existing obesity; long-term follow-up warranted

Summary Table

Key Points for Examination

1. Definition: < 8 years girls, < 9 years boys
2. Gold standard test: GnRH stimulation test (peak LH ≥8 IU/L = pubertal)
3. Most common cause in girls: Idiopathic/constitutional
4. Most common organic cause of CPP: Hypothalamic hamartoma
5. Hallmark of testotoxicosis: Small testes + virilization + very low LH + activating LH receptor mutation
6. McCune-Albright triad: Precocious puberty + polyostotic fibrous dysplasia + café-au-lait spots (GNAS1 mutation)
7. Hypothyroidism-associated PP: Only type with growth delay (Van Wyk-Grumbach syndrome)
8. Treatment of CPP: Long-acting GnRH analogue depot (leuprolide, triptorelin)
9. Most important complication: Short final adult stature
10. Benign variants: Premature thelarche, premature adrenarche, isolated premature menarche - all require follow-up but generally no treatment